| Literature DB >> 29928944 |
Pei-Yue Jiang1, Xiao-Jun Zhu1, Yi-Na Zhang1, Fei-Fei Zhou1, Xiao-Fu Yang2.
Abstract
Endometritis is a puzzling disease that often associates with severe pelvic pain. In this study, we aimed to detect whether apigenin had protective effect against LPS-induced endometritis, if so, the underlying mechanism was further investigated. Apigenin was administrated 1 h before LPS treatment. The levels of inflammatory cytokines were measured by ELISA. The expression of NF-κB and Nrf2 were detected by Western blot analysis. The results showed that LPS treatment induced severe histological alteration of uterus and this change was attenuated by the treatment of apigenin. Apigenin significantly attenuated LPS-induced MPO activity, MDA content, and inflammatory cytokines TNF-α and IL-1β production. LPS-induced NF-κB activation was suppressed by apigenin. Furthermore, apigenin elevated the expression of Nrf2 and HO-1 in uterine tissues. In conclusion, the present study demonstrated that apigenin protected against LPS-induced endometritis through activation of Nrf2 signaling pathway and inhibition of NF-κB signaling pathway.Entities:
Keywords: Apigenin; Endometritis; LPS; Nrf2
Mesh:
Substances:
Year: 2018 PMID: 29928944 DOI: 10.1016/j.micpath.2018.06.031
Source DB: PubMed Journal: Microb Pathog ISSN: 0882-4010 Impact factor: 3.738